Cardio Diagnostics Holdings, Inc. (CDIO) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)
- Cardio Diagnostics Holdings, Inc. CDIO 1.69 −3.98%
- Reviva Pharmaceuticals Holdings, Inc. RVPH 0.45 −6.25%
Cardio Diagnostics Holdings, Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.2M and $5.0M). Reviva Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −44,312.3%) and the higher return on invested capital (0.00% vs −219.4%). Across the 13 metrics below, Reviva Pharmaceuticals Holdings, Inc. leads on 7 and Cardio Diagnostics Holdings, Inc. on 6.
Valuation
Profitability
| Metric | CDIO | RVPH | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (44,230.82%) | 0.00% | 0.00% |
| Net margin | (44,312.33%) | 0.00% | 0.00% |
| Free cash flow margin | (39,893.15%) | 0.00% | 0.00% |
| Return on equity | (75.44%) | (176.60%) | (56.36%) |
| Return on assets | (70.62%) | (79.46%) | (48.04%) |
| Return on invested capital | (219.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack